Our Mission
A handful of stem cell transplants proved HIV can be cured. SHIELD HIV exists to learn how — at the level of specific donor T cells — and to turn that knowledge into a therapy that does not require a transplant.
Those cases prove cure is possible-but transplant is too toxic, rare, and complex to offer to the roughly 40 million people living with HIV worldwide. SHIELD HIV asks a practical question: What did the donor immune system actually do to erase the HIV reservoir-and can we copy that with targeted T-cell therapy?